Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Allory

Showing results (91-100 of 230) with videos related to

Pageof 23
Sort By:
International Journal of Molecular Sciences|May 14, 2022
Overexpression of Nucleolin and Associated Genes in Prostate CancerVirginie Firlej, Pascale Soyeux, Maya Nourieh, et al.
European Urology|June 16, 2012
Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategyGuillaume Ploussard, Nathalie Nicolaiew, Charles Marchand, et al.
Urology|August 29, 2012
Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomyAlexandre Campeggi, Evanguelos Xylinas, Guillaume Ploussard, et al.
Cancers|March 28, 2020
Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an <i>FGFR3</i> Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary PhenotypeVeronika Weyerer, Markus Eckstein, Eva Compérat, et al.
BJU International|October 2, 2010
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patientsGuillaume Ploussard, Mohammad Ali Agamy, Olivier Alenda, et al.
Scientific Reports|October 7, 2020
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancerConstance Le Goux, Sophie Vacher, Anne Schnitzler, et al.
BJU International|November 8, 2008
Prognostic significance of microscopic bladder neck invasion in prostate cancerFrancisco Rodríguez-Covarrubias, Stéphane Larré, Mickael Dahan, et al.
BMC Urology|May 12, 2025
Characteristics, management and survival outcomes in patients with muscle-invasive bladder cancer at high risk of recurrence in France: a subgroup analysis from the coblance cohortAldéric Fraslin, Florian Colrat, Maryam Karimi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2022
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER TrialChristian Pfister, Gwenaelle Gravis, Aude Fléchon, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 12, 2026
Multicentre Validation of the 2019 Briganti Nomogram: One Threshold Does Not Fit AllArthur Peyrottes, Fanny Orlhac, Alexandre Colau, et al.
Pageof 23

Showing results (91-100 of 230) with videos related to

Sort By:
Pageof 23
International Journal of Molecular Sciences|May 14, 2022
Overexpression of Nucleolin and Associated Genes in Prostate CancerVirginie Firlej, Pascale Soyeux, Maya Nourieh, et al.
European Urology|June 16, 2012
Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategyGuillaume Ploussard, Nathalie Nicolaiew, Charles Marchand, et al.
Urology|August 29, 2012
Impact of body mass index on perioperative morbidity, oncological, and functional outcomes after extraperitoneal laparoscopic radical prostatectomyAlexandre Campeggi, Evanguelos Xylinas, Guillaume Ploussard, et al.
Cancers|March 28, 2020
Pure Large Nested Variant of Urothelial Carcinoma (LNUC) Is the Prototype of an <i>FGFR3</i> Mutated Aggressive Urothelial Carcinoma with Luminal-Papillary PhenotypeVeronika Weyerer, Markus Eckstein, Eva Compérat, et al.
BJU International|October 2, 2010
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patientsGuillaume Ploussard, Mohammad Ali Agamy, Olivier Alenda, et al.
Scientific Reports|October 7, 2020
Assessment of prognostic implication of a panel of oncogenes in bladder cancer and identification of a 3-gene signature associated with recurrence and progression risk in non-muscle-invasive bladder cancerConstance Le Goux, Sophie Vacher, Anne Schnitzler, et al.
BJU International|November 8, 2008
Prognostic significance of microscopic bladder neck invasion in prostate cancerFrancisco Rodríguez-Covarrubias, Stéphane Larré, Mickael Dahan, et al.
BMC Urology|May 12, 2025
Characteristics, management and survival outcomes in patients with muscle-invasive bladder cancer at high risk of recurrence in France: a subgroup analysis from the coblance cohortAldéric Fraslin, Florian Colrat, Maryam Karimi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2022
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients With Nonmetastatic Muscle-Invasive Bladder Cancer: Results of the GETUG-AFU V05 VESPER TrialChristian Pfister, Gwenaelle Gravis, Aude Fléchon, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|May 12, 2026
Multicentre Validation of the 2019 Briganti Nomogram: One Threshold Does Not Fit AllArthur Peyrottes, Fanny Orlhac, Alexandre Colau, et al.
Pageof 23